• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALCON RESEARCH, LLC - HUNTINGTON ACRYSOF IQ NATURAL SINGLEPIECE IOL; INTRAOCULAR LENS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALCON RESEARCH, LLC - HUNTINGTON ACRYSOF IQ NATURAL SINGLEPIECE IOL; INTRAOCULAR LENS Back to Search Results
Model Number SN60WF
Medical Device Problem Code Dent in Material (2526)
Health Effect - Clinical Codes Corneal Edema (1791); Visual Impairment (2138)
Date of Event 02/16/2024
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Investigation including root cause analysis is in progress.A supplemental mdr will be filed as necessary in accordance with 21 cfr 803.56 when additional reportable information becomes available.The manufacturer internal reference number is: (b)(4).
 
Event or Problem Description
A health care professional reported that following an intraocular lens (iol) implant procedure, the patient experienced edema in cornea and also observed that the lens had stripes which was interfering with the vision and the lens was planned to be explanted.Additional information has been requested.
 
Event or Problem Description
Additional information was received, the lens was exchanged for another lens model 07 days following the initial procedure without complications.
 
Additional Manufacturer Narrative
The product was not returned.Product history records were reviewed and documentation indicated the product met release criteria.A qualified cartridge and viscoelastic were indicated with an unidentified handpiece.The product investigation could not identify a root cause for the reported edema and lens damage "stripes on lens".The product was not returned.It is unknown if a qualified handpiece was used.The instructions for use (ifu) instructs: company foldable intra ocular lens (iol) are qualified for use with an company qualified delivery system (handpiece and cartridge) and ophthalmic viscosurgical device (ovd) combination.The ifu instructs that an company qualified delivery system and viscoelastic combination should be used.The use of an unqualified combination may cause damage to the lens and potential complications during the implantation process.The ifu instructs to completely fill the cartridge with ovd immediately prior to loading and delivery of the lens.Do not attempt to load the lens without adequate ovd in the device.Not adequately filling the device with viscoelastic will result in inadequate coverage of lens and the lens fold path with ovd, which may result in damage.The ifu instructs: using holding forceps, grasp the lens by the optic edge and gently place the lens anterior side up into the back of the ovd-filled cartridge.The lens should be inserted until the optic is a little more than half-way inside the cartridge.Use the holding forceps to gently push down on the lens, verifying that the lens is on the bottom surface of the cartridge.Using holding forceps, take the trailing haptic, and gently fold the haptic onto the anterior side of the optic.Slowly grip or push the optic edge to position the lens as far into the cartridge as the forceps will permit, while ensuring the lens remains on the bottom surface of the cartridge and the trailing haptic remains on the optic.Failure to follow these steps may cause the lens to advance incorrectly causing delivery issues and/or damage.Information was provided that the lens was replaced with an unspecified company model lens with no issue reported.The manufacturer internal reference number is: (b)(4).
 
Additional Manufacturer Narrative
Lens was returned suspended in liquid, inside of a syringe.Viscoelastic was present on the lens.Two cut marks were observed, one extending from the optic edge across the center.Two smaller cuts were observed at the edge of the optic, near one haptic.Light scuff marks/scratches were observed at the center of the optic, on both the anterior and posterior sides.It cannot be determined if this damage was caused during the lens removal.It cannot be determined is this was the reported stripes.The manufacturer internal reference number is: (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ACRYSOF IQ NATURAL SINGLEPIECE IOL
Common Device Name
INTRAOCULAR LENS
Manufacturer (Section D)
ALCON RESEARCH, LLC - HUNTINGTON
6065 kyle lane
huntington WV 25702
Manufacturer (Section G)
ALCON RESEARCH, LLC - HUNTINGTON
6065 kyle lane
huntington WV 25702
Manufacturer Contact
jonathan schlech
6201 south freeway
mail stop ab2-6
fort worth, TX 76134
8007579780
MDR Report Key18912973
Report Number1119421-2024-00498
Device Sequence Number12485850
Product Code HQL
UDI-Device Identifier00380655093146
UDI-Public(01)00380655093146(17)280611(11)230614(10)15662004(21)15662004041
Combination Product (Y/N)N
Initial Reporter CountryMX
PMA/510(K) Number
P930014
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2024
Device Explanted Year2024
Reporter Type Manufacturer
Report Source Foreign,Health Professional
Initial Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date (Section B) 09/02/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model NumberSN60WF
Device Catalogue NumberSN60WF.175
Device Lot Number15662004
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Follow-Up
Initial Date Received by Manufacturer 02/20/2024
Supplement Date Received by Manufacturer04/26/2024
08/07/2024
Initial Report FDA Received Date03/15/2024
Supplement Report FDA Received Date05/23/2024
09/02/2024
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured06/14/2023
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
CENTURION VISION SYSTEM, ACTIVE SENTRY HANDPIECE; DISCOVISC OPHTHALMIC VISCOSURGICAL DEVICE; MONARCH III IOL DELIVERY SYSTEM, CARTRIDGE D; MONARCH IOL DELIVERY SYSTEM, INJECTOR; UNSPECIFIED REPLACEMENT LENS
Outcome Attributed to Adverse Event Other;
Patient SexUnknown
-
-